These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21214668)

  • 21. Successful treatment of moderate to severe melasma with triple-combination cream and glycolic acid peels: a pilot study.
    Rendon M; Cardona LM; Bussear EW; Benitez AL; Colón LE; Johnson LA
    Cutis; 2008 Nov; 82(5):372-8. PubMed ID: 19090343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of fractional erbium-glass laser and topical therapy in melasma resistant to triple-combination cream.
    Tourlaki A; Galimberti MG; Pellacani G; Bencini PL
    J Dermatolog Treat; 2014 Jun; 25(3):218-22. PubMed ID: 22385073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement of idiopathic acanthosis nigricans with a triple combination depigmenting cream.
    Adigun CG; Pandya AG
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):486-7. PubMed ID: 18721216
    [No Abstract]   [Full Text] [Related]  

  • 24. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians.
    Wattanakrai P; Mornchan R; Eimpunth S
    Dermatol Surg; 2010; 36(1):76-87. PubMed ID: 20298254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treating epidermal melasma with a 4% hydroquinone skin care system plus tretinoin cream 0.025%.
    Grimes P; Watson J
    Cutis; 2013 Jan; 91(1):47-54. PubMed ID: 23461059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Punctate leucoderma after low-fluence 1,064-nm quality-switched neodymium-doped yttrium aluminum garnet laser therapy successfully managed using a 308-nm excimer laser.
    Kim HS; Jung HD; Kim HO; Lee JY; Park YM
    Dermatol Surg; 2012 May; 38(5):821-3. PubMed ID: 22540921
    [No Abstract]   [Full Text] [Related]  

  • 27. Cost-effectiveness of a hydroquinone/tretinoin/fluocinolone acetonide cream combination in treating melasma in the United States.
    Alikhan A; Daly M; Wu J; Balkrishnan R; Feldman SR
    J Dermatolog Treat; 2010 Sep; 21(5):276-81. PubMed ID: 20055711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful treatment of melasma using a combination of microdermabrasion and Q-switched Nd:YAG lasers.
    Kauvar AN
    Lasers Surg Med; 2012 Feb; 44(2):117-24. PubMed ID: 22334295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-ablative 1,550 nm fractional laser therapy versus triple topical therapy for the treatment of melasma: a randomized controlled split-face study.
    Wind BS; Kroon MW; Meesters AA; Beek JF; van der Veen JP; Nieuweboer-Krobotová L; Bos JD; Wolkerstorfer A
    Lasers Surg Med; 2010 Sep; 42(7):607-12. PubMed ID: 20806385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of a new triple-combination agent for the treatment of facial melasma.
    Taylor SC; Torok H; Jones T; Lowe N; Rich P; Tschen E; Menter A; Baumann L; Wieder JJ; Jarratt MM; Pariser D; Martin D; Weiss J; Shavin J; Ramirez N
    Cutis; 2003 Jul; 72(1):67-72. PubMed ID: 12889718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, observer-blinded, comparison of combined 1064-nm Q-switched neodymium-doped yttrium-aluminium-garnet laser plus 30% glycolic acid peel vs. laser monotherapy to treat melasma.
    Park KY; Kim DH; Kim HK; Li K; Seo SJ; Hong CK
    Clin Exp Dermatol; 2011 Dec; 36(8):864-70. PubMed ID: 21973194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Commentary on Clinical and Histopathological Assessment of Facial Melasma After Low-Fluence Q-Switched Neodymium-Doped Yttrium Aluminium Garnet Laser.
    Morton LM
    Dermatol Surg; 2016 Apr; 42(4):513-4. PubMed ID: 26949932
    [No Abstract]   [Full Text] [Related]  

  • 33. Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12-month treatment for melasma.
    Torok HM; Jones T; Rich P; Smith S; Tschen E
    Cutis; 2005 Jan; 75(1):57-62. PubMed ID: 15732437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melasma in Latin America: options for therapy and treatment algorithm.
    Cestari T; Arellano I; Hexsel D; Ortonne JP;
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):760-72. PubMed ID: 19646135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The evolution of melasma therapy: targeting melanosomes using low-fluence Q-switched neodymium-doped yttrium aluminium garnet lasers.
    Kauvar AN
    Semin Cutan Med Surg; 2012 Jun; 31(2):126-32. PubMed ID: 22640433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of a novel picosecond laser using combination of 1 064 and 595 nm on patients with melasma: A prospective, randomized, multicenter, split-face, 2% hydroquinone cream-controlled clinical trial.
    Choi YJ; Nam JH; Kim JY; Min JH; Park KY; Ko EJ; Kim BJ; Kim WS
    Lasers Surg Med; 2017 Dec; 49(10):899-907. PubMed ID: 28906574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and Histopathologic Assessment of Facial Melasma After Low-Fluence Q-Switched Neodymium-Doped Yttrium Aluminium Garnet Laser.
    Hofbauer Parra CA; Careta MF; Valente NY; de Sanches Osório NE; Torezan LA
    Dermatol Surg; 2016 Apr; 42(4):507-12. PubMed ID: 26963146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erythema ab igne successfully treated using 1,064-nm Q-switched neodymium-doped yttrium aluminum garnet laser with low fluence.
    Cho S; Jung JY; Lee JH
    Dermatol Surg; 2011 Apr; 37(4):551-3. PubMed ID: 21481074
    [No Abstract]   [Full Text] [Related]  

  • 39. Triple combination and glycolic acid peels in melasma in Indian patients.
    Godse KV; Sakhia J
    J Cosmet Dermatol; 2011 Mar; 10(1):68-9. PubMed ID: 21332917
    [No Abstract]   [Full Text] [Related]  

  • 40. A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate to severe facial melasma.
    Ferreira Cestari T; Hassun K; Sittart A; de Lourdes Viegas M
    J Cosmet Dermatol; 2007 Mar; 6(1):36-9. PubMed ID: 17348994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.